Induction of IL-6 led to phosphorylation of STAT3 via JAK, resulting in downregulation of ER, occurrence of EMT and cancer stem-like phenotype that could be counteracted by Napabucasin, a newly developed small inhibitor of STAT3. Here, STAT3 is linked to cancer.